Precision Biosciences (DTIL) Shares Outstanding (Weighted Average) (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Shares Outstanding (Weighted Average) data on file, last reported at $24.6 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $24.6 million, up 165.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.6 million (up 165.11% YoY), and the FY2025 annual result was $12.8 million, up 87.71% from the prior year.
• Shares Outstanding (Weighted Average) improved to $24.6 million in Q1 2026 per DTIL's latest filing, from $12.8 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $80.1 million in Q3 2022 and troughed at $2.9 million in Q4 2022.
• A 5-year average of $18.7 million and a median of $7.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Weighted Average) slumped 95.21% in 2023, then jumped 165.11% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.9 million in 2022, then surged by 31.11% to $3.8 million in 2023, then surged by 77.88% to $6.8 million in 2024, then soared by 87.71% to $12.8 million in 2025, then surged by 92.07% to $24.6 million in 2026.
• Business Quant data shows DTIL's Shares Outstanding (Weighted Average) at $24.6 million in Q1 2026, $12.8 million in Q4 2025, and $10.7 million in Q3 2025.